These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15294002)
1. Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor. Tahtaoui C; Parrot I; Klotz P; Guillier F; Galzi JL; Hibert M; Ilien B J Med Chem; 2004 Aug; 47(17):4300-15. PubMed ID: 15294002 [TBL] [Abstract][Full Text] [Related]
2. Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands. Daval SB; Kellenberger E; Bonnet D; Utard V; Galzi JL; Ilien B Mol Pharmacol; 2013 Jul; 84(1):71-85. PubMed ID: 23604140 [TBL] [Abstract][Full Text] [Related]
3. On the use of nonfluorescent dye labeled ligands in FRET-based receptor binding studies. Tahtaoui C; Guillier F; Klotz P; Galzi JL; Hibert M; Ilien B J Med Chem; 2005 Dec; 48(24):7847-59. PubMed ID: 16302823 [TBL] [Abstract][Full Text] [Related]
4. Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors. Daval SB; Valant C; Bonnet D; Kellenberger E; Hibert M; Galzi JL; Ilien B J Med Chem; 2012 Mar; 55(5):2125-43. PubMed ID: 22329602 [TBL] [Abstract][Full Text] [Related]
5. A fluorescence anisotropy assay for the muscarinic M1 G-protein-coupled receptor. Huwiler KG; De Rosier T; Hanson B; Vogel KW Assay Drug Dev Technol; 2010 Jun; 8(3):356-66. PubMed ID: 20233092 [TBL] [Abstract][Full Text] [Related]
6. Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process. Ilien B; Glasser N; Clamme JP; Didier P; Piemont E; Chinnappan R; Daval SB; Galzi JL; Mely Y J Biol Chem; 2009 Jul; 284(29):19533-43. PubMed ID: 19451648 [TBL] [Abstract][Full Text] [Related]
7. A rapid and versatile method to label receptor ligands using "click" chemistry: Validation with the muscarinic M1 antagonist pirenzepine. Bonnet D; Ilien B; Galzi JL; Riché S; Antheaune C; Hibert M Bioconjug Chem; 2006; 17(6):1618-23. PubMed ID: 17105244 [TBL] [Abstract][Full Text] [Related]
8. Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties. Ilien B; Franchet C; Bernard P; Morisset S; Weill CO; Bourguignon JJ; Hibert M; Galzi JL J Neurochem; 2003 May; 85(3):768-78. PubMed ID: 12694403 [TBL] [Abstract][Full Text] [Related]
10. Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors. Gharagozloo P; Lazareno S; Popham A; Birdsall NJ J Med Chem; 1999 Feb; 42(3):438-45. PubMed ID: 9986715 [TBL] [Abstract][Full Text] [Related]
11. FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors. Ziegler N; Bätz J; Zabel U; Lohse MJ; Hoffmann C Bioorg Med Chem; 2011 Feb; 19(3):1048-54. PubMed ID: 20716489 [TBL] [Abstract][Full Text] [Related]
12. Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7. Fruchart-Gaillard C; Mourier G; Marquer C; Ménez A; Servent D Mol Pharmacol; 2006 May; 69(5):1641-51. PubMed ID: 16439611 [TBL] [Abstract][Full Text] [Related]
13. Development of a new type of allosteric modulator of muscarinic receptors: hybrids of the antagonist AF-DX 384 and the hexamethonio derivative W84. Mohr M; Heller E; Ataie A; Mohr K; Holzgrabe U J Med Chem; 2004 Jun; 47(12):3324-7. PubMed ID: 15163212 [TBL] [Abstract][Full Text] [Related]
14. Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex. De Lorme KC; Grant MK; Noetzel MJ; Polson SB; El-Fakahany EE J Pharmacol Exp Ther; 2007 Dec; 323(3):868-76. PubMed ID: 17855477 [TBL] [Abstract][Full Text] [Related]
15. Position-specific incorporation of fluorescent non-natural amino acids into maltose-binding protein for detection of ligand binding by FRET and fluorescence quenching. Iijima I; Hohsaka T Chembiochem; 2009 Apr; 10(6):999-1006. PubMed ID: 19301314 [TBL] [Abstract][Full Text] [Related]
16. The effects of mercury on muscarinic cholinergic receptor subtypes (M1 and M2) in captive mink. Basu N; Scheuhammer AM; Rouvinen-Watt K; Evans RD; Grochowina N; Chan LH Neurotoxicology; 2008 Mar; 29(2):328-34. PubMed ID: 18295336 [TBL] [Abstract][Full Text] [Related]
17. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells. Middleton RJ; Briddon SJ; Cordeaux Y; Yates AS; Dale CL; George MW; Baker JG; Hill SJ; Kellam B J Med Chem; 2007 Feb; 50(4):782-93. PubMed ID: 17249651 [TBL] [Abstract][Full Text] [Related]
18. Functional characterization and potential applications for enhanced green fluorescent protein- and epitope-fused human M1 muscarinic receptors. Weill C; Galzi JL; Chasserot-Golaz S; Goeldner M; Ilien B J Neurochem; 1999 Aug; 73(2):791-801. PubMed ID: 10428077 [TBL] [Abstract][Full Text] [Related]
19. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors. Hamrouni AM; Gudka N; Broadley KJ Auton Autacoid Pharmacol; 2006 Jul; 26(3):275-84. PubMed ID: 16879493 [TBL] [Abstract][Full Text] [Related]